About Biodeal Pharmaceuticals
Biodeal Pharmaceuticals is a company based in Delhi (India) founded in 2007 by Anurag Kumar. Biodeal Pharmaceuticals has raised $13.2 million across 1 funding round from investors including Piramal Group. The company has 343 employees as of April 10, 2025. Biodeal Pharmaceuticals offers products and services including Domestic Pharmaceuticals, Nutraceuticals, Export Pharmaceuticals, and Derma and Cosmetics. Biodeal Pharmaceuticals operates in a competitive market with competitors including Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.
- Headquarter Delhi, India
- Employees 343 as on 10 Apr, 2025
- Founders Anurag Kumar
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Biodeal Pharmaceuticals Limited
- Date of Incorporation 30 Dec, 2005
- Jurisdiction Nalagarh, Distt. Solan (Hp)., Himachal Pradesh, India
-
Annual Revenue
$16.78 M (USD)41.92as on Mar 31, 2024
-
Net Profit
$1.29 M (USD)90.53as on Mar 31, 2024
-
EBITDA
$5.87 M (USD)177.98as on Mar 31, 2024
-
Total Equity Funding
$13.2 M (USD)
in 1 rounds
-
Latest Funding Round
$13.2 M (USD), Series B
Apr 08, 2024
- Investors
-
Employee Count
343
as on Apr 10, 2025
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Biodeal Pharmaceuticals
Biodeal Pharmaceuticals offers a comprehensive portfolio of products and services, including Domestic Pharmaceuticals, Nutraceuticals, Export Pharmaceuticals, and Derma and Cosmetics.
Manufactures drugs for Indian market with quality standards.
Produces nutritional products for health and wellness.
Develops formulations for international markets.
Creates skin care products for consumer use.
People of Biodeal Pharmaceuticals
Unlock access to complete
Unlock access to complete
Funding Insights of Biodeal Pharmaceuticals
Biodeal Pharmaceuticals has successfully raised a total of $13.2M through 1 strategic funding round. The most recent funding activity was a Series B round of $13.2 million completed in April 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Biodeal Pharmaceuticals
Biodeal Pharmaceuticals has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Piramal Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multinational conglomerate with diverse interests in Pharma, Financial Services and Real Estate
|
Locked | Locked | Locked |
Investor details for Biodeal Pharmaceuticals
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Biodeal Pharmaceuticals
Investment portfolio details for Biodeal Pharmaceuticals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Biodeal Pharmaceuticals
Detailed financials for Biodeal Pharmaceuticals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Biodeal Pharmaceuticals Comparisons
Peer comparison for Biodeal Pharmaceuticals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Biodeal Pharmaceuticals
Biodeal Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Contract development and manufacturing organization for proprietary and generic drugs
|
|
| Locked | Locked | Locked |
CDMO focusing on spectrum of dosage forms and therapeutic segments
|
|
| Locked | Locked | Locked |
Company offering a suite of R&D and manufacturing services for small molecules and generics
|
|
| Locked | Locked | Locked |
Pharmaceutical development and manufacturing services are offered contractually.
|
|
| Locked | Locked | Locked |
CDMO with a focus on early phase drug product development
|
|
| Locked | Locked | Locked |
Cephalosporin APIs and generic formulations are manufactured.
|
Detailed competitors of Biodeal Pharmaceuticals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Biodeal Pharmaceuticals
Complete news archive for Biodeal Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biodeal Pharmaceuticals
Biodeal Pharmaceuticals was founded in 2007 and raised its 1st funding round 17 years after it was founded.
Biodeal Pharmaceuticals is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
Biodeal Pharmaceuticals is a funded company, having raised a total of $13.2M across 1 funding round to date.
As of Apr 10, 2025, the latest employee count at Biodeal Pharmaceuticals is 343.
Annual revenue of Biodeal Pharmaceuticals is $16.78M as on Mar 31, 2024.
Biodeal Pharmaceuticals was established in 2007 in Delhi, India, as a manufacturer of pharmaceutical formulations. Operations are centered on producing various drug formulations for the healthcare sector. The company is led by founder Anurag Kumar, serving as Managing Director. Activities are conducted from its base in Delhi, with a focus on standard pharmaceutical production processes. The domain biodealpharma.com is utilized for online presence.
Biodeal Pharmaceuticals's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
Biodeal Pharmaceuticals offers Domestic Pharmaceuticals, Nutraceuticals, Export Pharmaceuticals, and Derma and Cosmetics.
Biodeal Pharmaceuticals has 1 investor. Key investors include Piramal Group.